Showing results (111-120 of 394) with videos related to
Sort By:
Pageof 40
Stem Cells (Dayton, Ohio)|July 21, 2007
Global epiproteomic signatures distinguish embryonic stem cells from differentiated cellsBo Dai, Theodore P RasmussenAmerican Journal of Clinical Pathology|June 1, 1987
Pneumocystis carinii involvement of the bone marrow in acquired immunodeficiency syndromeM R Heyman, P RasmussenActa Anaesthesiologica Scandinavica|January 1, 1975
Cardiac function during halothane anf fluroxene anesthesia expressed by systolic time intervalsJ P Rasmussen, B SorensenPlos One|July 9, 2011
X chromosome inactivation and differentiation occur readily in ES cells doubly-deficient for macroH2A1 and macroH2A2Borko Tanasijevic, Theodore P RasmussenDiabetes Care|July 2, 1999
Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetesT J Berg, O Snorgaard, J Faber, et al.Diabetologia|August 26, 2011
Perinatal and infant mortality in term and preterm births among women with type 1 diabetesI Eidem, S Vangen, K F Hanssen, et al.Diabetologia|March 11, 2005
Mean HbA1c over 18 years predicts carotid intima media thickness in women with type 1 diabetesJ R Larsen, M Brekke, L Bergengen, et al.Diabetic Medicine : a Journal of the British Diabetic Association|January 10, 2003
Heterogeneity of non-insulin-dependent diabetes expressed as variability in insulin sensitivity, beta-cell function and cardiovascular risk profileK I Birkeland, B Kilhovd, P Thorsby, et al.Diabetologia|May 5, 2007
Increased serum levels of advanced glycation endproducts predict total, cardiovascular and coronary mortality in women with type 2 diabetes: a population-based 18 year follow-up studyB K Kilhovd, A Juutilainen, S Lehto, et al.Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 9, 2000
[Prevention of cardiovascular disease in type 2 diabetes]K I Birkeland, T Claudi, V Hansteen, et al.Pageof 40